Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-4199

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 70518-4199). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a prescription medication for Rosuvastatin 20 mg tablets, with a quantity of 90 tablets. The medication is manufactured by Glenmark in Mahwah, NJ. The NDC number is 70518-4199-00 and the source NDC is 68462-0263-10. The medication should be stored at 20-25°C (58-77°F), with excursions permitted to 15.30°C (59-86°F). The directions for use can be found in the package insert. It is important to keep this medication out of the reach of children.*

FDA Label Image

Figure1 (Figure1)

This text provides information on the efficacy of a treatment, with a hazard ratio (HR) of 0.56 and a 95% confidence interval (CI) of 0.46-0.69. It also indicates a significant result (p<0.001) with regards to cumulative incidence in terms of percentage. The table below shows the number of individuals at risk in each group over time.*

FDA Label Image

Figure2 (Figure2)

This text provides data from a study comparing the effects of Rosuvastatin 20 mg and Placebo 20 mg on various cardiovascular endpoints in a sample of 8901 patients. The results show a significant reduction in the primary endpoint (MCE) with Rosuvastatin compared to Placebo. Furthermore, Rosuvastatin showed favorable outcomes in terms of cardiovascular death, nonfatal stroke, nonfatal myocardial infarction (MI), unstable angina, and arterial revascularization. These findings suggest that Rosuvastatin may be effective in reducing the risk of cardiovascular events in this population.*

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.